New-DES vs BMS in SVG -1 Year Outcomes
- Conditions
- Coronary Artery Disease
- Interventions
- Device: new-DESDevice: BMS
- Registration Number
- NCT04338308
- Lead Sponsor
- Medical University of Silesia
- Brief Summary
Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare one-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 792
- patients after CABG with significant SVG stenosis referred for PCI
- patients who had both types of stents implanted in the same procedure
- patients with the old-DES
- patients who had PCI of other vascular territories during the same procedure
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description SVG PCI new-DES - SVG PCI BMS -
- Primary Outcome Measures
Name Time Method major adverse cardiac and cerebrovascular event 1 year
- Secondary Outcome Measures
Name Time Method stroke 1 year target lesion revascularization 1 year death 1 year myocardial infarction 1 year target vessel revascularization 1 year
Trial Locations
- Locations (3)
First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland
🇵🇱Gdańsk, Poland
Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland
🇵🇱Kraków, Poland
Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
🇵🇱Katowice, Poland